10.91% of Kiromic BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kiromic BioPharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2023	Susquehanna International Group LLP	16,457	$64K	0.0%	N/A	1.681%
5/13/2022	Renaissance Technologies LLC	56,111	$48K	0.0%	N/A	0.360%
5/13/2022	Warberg Asset Management LLC	73,847	$63K	0.0%	+118.4%	0.474%
5/5/2022	Lynwood Capital Management Inc.	300,000	$0.26M	0.3%	-19.5%	1.924%
4/21/2022	K.J. Harrison & Partners Inc	48,233	$41K	0.0%	+83.9%	0.309%
1/26/2022	K.J. Harrison & Partners Inc	26,233	$40K	0.0%	+54.3%	0.170%
12/27/2021	Zeke Capital Advisors LLC	56,899	$0.18M	0.0%	+236.7%	0.369%
11/16/2021	Intellectus Partners LLC	98,850	$0.30M	0.1%	+32.0%	0.640%
11/16/2021	Warberg Asset Management LLC	12,000	$37K	0.0%	-81.0%	0.078%
11/12/2021	1492 Capital Management LLC	434,408	$1.33M	0.7%	+21.3%	2.814%
11/9/2021	BlackRock Inc.	30,645	$94K	0.0%	+218.3%	0.198%
11/5/2021	Resources Investment Advisors LLC.	10,000	$31K	0.0%	N/A	0.065%
11/5/2021	K.J. Harrison & Partners Inc	17,002	$52K	0.0%	N/A	0.110%
10/14/2021	WealthTrust Axiom LLC	10,000	$30K	0.0%	N/A	0.065%
8/17/2021	Zeke Capital Advisors LLC	16,899	$81K	0.0%	-64.0%	0.110%
8/16/2021	Warberg Asset Management LLC	63,000	$0.30M	0.1%	N/A	0.409%
8/16/2021	Sabby Management LLC	500,508	$2.41M	0.3%	N/A	3.253%
8/16/2021	Shay Capital LLC	25,000	$0.12M	0.0%	N/A	0.162%
8/13/2021	Altium Capital Management LP	333,475	$1.60M	0.4%	N/A	2.167%
8/13/2021	Murchinson Ltd.	100,000	$0.48M	0.2%	N/A	0.650%
8/13/2021	Intellectus Partners LLC	74,900	$0.36M	0.1%	+96.3%	0.487%
8/13/2021	Vanguard Group Inc.	119,304	$0.57M	0.0%	+1,045.6%	0.775%
8/12/2021	Kepos Capital LP	767,000	$3.69M	0.3%	N/A	4.985%
5/21/2021	Citadel Advisors LLC	21,725	$0.20M	0.0%	+86.7%	0.295%
5/18/2021	Citadel Advisors LLC	21,725	$0.20M	0.0%	+86.7%	0.296%
5/17/2021	Intellectus Partners LLC	38,150	$0.36M	0.1%	+8.2%	0.520%
5/12/2021	1492 Capital Management LLC	185,937	$1.74M	1.0%	N/A	2.536%
5/7/2021	BlackRock Inc.	5,117	$48K	0.0%	+45.0%	0.070%
5/6/2021	Redmond Asset Management LLC	45,412	$0.43M	0.1%	N/A	0.619%
4/21/2021	Zeke Capital Advisors LLC	46,999	$0.44M	0.0%	-2.9%	0.641%
2/18/2021	Intellectus Partners LLC	35,250	$0.30M	0.1%	N/A	0.481%
2/5/2021	BlackRock Inc.	3,529	$30K	0.0%	N/A	0.048%

Data available starting January 2016

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company develops ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Today's Range

Now: $2.50

$2.50

50 Day Range

MA: $2.63

$1.49

$3.46

52 Week Range

Now: $2.50

$0.16

$8.97

Volume

834 shs

Average Volume

8,650 shs

Market Capitalization

$3.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.